Schedule 13G ownership disclosure

OPIANT PHARMACEUTICALS INC

Security class unavailable · CUSIP: 683750103

Event date: 2019-05-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
252,873
Percent of class
6.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-19-004208
Form type
SC 13G
Filer
Altium Capital Management LLC
CIK
CIK 1746382
Filed
Jun 05, 2019
Reporting period
May 30, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub